109 related articles for article (PubMed ID: 28888921)
1. N(4)-[B-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan)methyl]-2'-deoxycytidine as a potential boron delivery agent with respect to glioblastoma.
Uram Ł; Nizioł J; Maj P; Sobich J; Rode W; Ruman T
Biomed Pharmacother; 2017 Nov; 95():749-755. PubMed ID: 28888921
[TBL] [Abstract][Full Text] [Related]
2. A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma.
Xiang J; Ma L; Gu Z; Jin H; Zhai H; Tong J; Liang T; Li J; Ren Q; Liu Q
Cells; 2022 Mar; 11(7):. PubMed ID: 35406737
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of the boronated porphyrin TABP-1 in U-87 MG intracerebral human glioblastoma xenografts.
Ozawa T; Santos RA; Lamborn KR; Bauer WF; Koo MS; Kahl SB; Deen DF
Mol Pharm; 2004; 1(5):368-74. PubMed ID: 16026007
[TBL] [Abstract][Full Text] [Related]
4. A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma:
Alamón C; Dávila B; García MF; Nievas S; Dagrosa MA; Thorp S; Kovacs M; Trias E; Faccio R; Gabay M; Zeineh N; Weizman A; Teixidor F; Viñas C; Gavish M; Cerecetto H; Couto M
Mol Pharm; 2023 May; 20(5):2702-2713. PubMed ID: 37013916
[TBL] [Abstract][Full Text] [Related]
5. Boron's neurophysiological effects and tumoricidal activity on glioblastoma cells with implications for clinical treatment.
Altinoz MA; Topcu G; Elmaci İ
Int J Neurosci; 2019 Oct; 129(10):963-977. PubMed ID: 30885023
[No Abstract] [Full Text] [Related]
6. Boron neutron capture therapy of primary and metastatic brain tumors.
Barth RF; Soloway AH
Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of N(4)-boronated derivatives of 2'-deoxycytidine, potential agents for boron-neutron capture therapy.
Nizioł J; Uram Ł; Szuster M; Sekuła J; Ruman T
Bioorg Med Chem; 2015 Oct; 23(19):6297-304. PubMed ID: 26344594
[TBL] [Abstract][Full Text] [Related]
9. A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma.
Luderer MJ; Muz B; de la Puente P; Chavalmane S; Kapoor V; Marcelo R; Biswas P; Thotala D; Rogers B; Azab AK
Pharm Res; 2016 Oct; 33(10):2530-9. PubMed ID: 27401411
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, reactivity and biological activity of N(4)-boronated derivatives of 2'-deoxycytidine.
Nizioł J; Zieliński Z; Leś A; Dąbrowska M; Rode W; Ruman T
Bioorg Med Chem; 2014 Aug; 22(15):3906-12. PubMed ID: 24999002
[TBL] [Abstract][Full Text] [Related]
11. Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.
Hill JS; Kahl SB; Stylli SS; Nakamura Y; Koo MS; Kaye AH
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12126-30. PubMed ID: 8618857
[TBL] [Abstract][Full Text] [Related]
12. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Okabe M; Kirihata M; Ono K; Kuroiwa T
Radiat Res; 2007 Jan; 167(1):102-9. PubMed ID: 17214510
[TBL] [Abstract][Full Text] [Related]
13. Promising potential of boron compounds against Glioblastoma: In Vitro antioxidant, anti-inflammatory and anticancer studies.
Turkez H; Arslan ME; Tatar A; Mardinoglu A
Neurochem Int; 2021 Oct; 149():105137. PubMed ID: 34293392
[TBL] [Abstract][Full Text] [Related]
14. Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
J Hematother; 1995 Oct; 4(5):477-83. PubMed ID: 8581388
[TBL] [Abstract][Full Text] [Related]
15. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Tjarks W; Lorey DR; Barth RF
J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
[TBL] [Abstract][Full Text] [Related]
16. Towards carborane-functionalised structures for the treatment of brain cancer.
Calabrese G; Daou A; Barbu E; Tsibouklis J
Drug Discov Today; 2018 Jan; 23(1):63-75. PubMed ID: 28886331
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
[TBL] [Abstract][Full Text] [Related]
18. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
19. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.
Nichols TL; Kabalka GW; Miller LF; Khan MK; Smith GT
Med Phys; 2002 Oct; 29(10):2351-8. PubMed ID: 12408309
[TBL] [Abstract][Full Text] [Related]
20. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
